Monte Rosa Therapeutics, Inc. (GLUE) › Shareholders' EquityMonte Rosa Therapeutics, Inc. (GLUE) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -$48.73M2021: $347.51M2022: $271.41M2023: $179.25M2024: $222.94M2025: $233.06M$233.06M2020Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$233.06M+4.5%2024$222.94M+24.4%2023$179.25M-34.0%2022$271.41M-21.9%2021$347.51M+813.2%2020-$48.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share